Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

2-LB: Semaglutide 2.4 mg Reduces the 10-Year T2D Risk in People with Overweight/Obesity

PaperCitations, authors & open-access status

2-LB: Semaglutide 2.4 mg Reduces the 10-Year T2D Risk in People with Overweight/Obesity is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 6 citations, 2022 year and closed oa status.

6
Citations
2022
Year
closed
OA Status

Related on ScholarIQ

Thomas Holst‐Hansen
Author
Diabetes Treatment and Management
Topic
Diabetes Treatment and Management
Topic
Metabolism, Diabetes, and Cancer
Topic
470M+ articles · free account